Pandey B, Thapa S, Biradar M, Singh B, Ghale J, Kharel P
PLoS One. 2024; 19(12):e0309797.
PMID: 39739862
PMC: 11687663.
DOI: 10.1371/journal.pone.0309797.
Aryee R, Mohammed N, Dey S, Arunraj B, Nadendla S, Sajeevan K
bioRxiv. 2024; .
PMID: 39345548
PMC: 11429904.
DOI: 10.1101/2024.09.16.613350.
Pires C, Moreno M
Membranes (Basel). 2024; 14(7).
PMID: 39057665
PMC: 11278619.
DOI: 10.3390/membranes14070157.
Burloiu A, Mihai D, Manda G, Lupuliasa D, Neagoe I, Socoteanu R
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931355
PMC: 11206637.
DOI: 10.3390/ph17060688.
Piciu F, Domocos D, Chiritoiu G, Chiritoiu-Butnaru M, Mernea M, Popescu C
Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543130
PMC: 10975152.
DOI: 10.3390/ph17030344.
The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.
Bergin C, Zouggar A, Mendes da Silva A, Fenouil T, Haebe J, Masibag A
Nat Cancer. 2024; 5(3):463-480.
PMID: 38351181
DOI: 10.1038/s43018-024-00727-y.
PractiCPP: a deep learning approach tailored for extremely imbalanced datasets in cell-penetrating peptide prediction.
Shi K, Xiong Y, Wang Y, Deng Y, Wang W, Jing B
Bioinformatics. 2024; 40(2).
PMID: 38305405
PMC: 11212486.
DOI: 10.1093/bioinformatics/btae058.
Assessment of Some Unsymmetrical Porphyrins as Promising Molecules for Photodynamic Therapy of Cutaneous Disorders.
Burloiu A, Manda G, Lupuliasa D, Socoteanu R, Mihai D, Neagoe I
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256895
PMC: 10818616.
DOI: 10.3390/ph17010062.
Combining SILCS and Artificial Intelligence for High-Throughput Prediction of the Passive Permeability of Drug Molecules.
Pandey P, MacKerell Jr A
J Chem Inf Model. 2023; 63(18):5903-5915.
PMID: 37682640
PMC: 10603762.
DOI: 10.1021/acs.jcim.3c00514.
Cytotoxicity Analysis and In Silico Studies of Three Plant Extracts with Potential Application in Treatment of Endothelial Dysfunction.
Ungureanu A, Popovici V, Oprean C, Danciu C, Schroder V, Olaru O
Pharmaceutics. 2023; 15(8).
PMID: 37631338
PMC: 10459174.
DOI: 10.3390/pharmaceutics15082125.
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods.
Mostofian B, Martin H, Razavi A, Patel S, Allen B, Sherman W
J Chem Inf Model. 2023; 63(17):5408-5432.
PMID: 37602861
PMC: 10498452.
DOI: 10.1021/acs.jcim.3c00603.
Interaction of Some Asymmetrical Porphyrins with U937 Cell Membranes-In Vitro and In Silico Studies.
Mihai D, Boscencu R, Manda G, Burloiu A, Vasiliu G, Neagoe I
Molecules. 2023; 28(4).
PMID: 36838628
PMC: 9959758.
DOI: 10.3390/molecules28041640.
In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction.
Ragab A, Badawy E, Aboukhatwa S, Kabbash A, Abo El-Seoud K
Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297282
PMC: 9609924.
DOI: 10.3390/ph15101171.
Metalloprotease Gp63-Targeting Novel Glycoside Exhibits Potential Antileishmanial Activity.
Chakrabarti A, Narayana C, Joshi N, Garg S, Garg L, Ranganathan A
Front Cell Infect Microbiol. 2022; 12:803048.
PMID: 35601095
PMC: 9115111.
DOI: 10.3389/fcimb.2022.803048.
Membrane thickness, lipid phase and sterol type are determining factors in the permeability of membranes to small solutes.
Frallicciardi J, Melcr J, Siginou P, Marrink S, Poolman B
Nat Commun. 2022; 13(1):1605.
PMID: 35338137
PMC: 8956743.
DOI: 10.1038/s41467-022-29272-x.
Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design.
Rog T, Girych M, Bunker A
Pharmaceuticals (Basel). 2021; 14(10).
PMID: 34681286
PMC: 8537670.
DOI: 10.3390/ph14101062.
A multiscale approach for bridging the gap between potency, efficacy, and safety of small molecules directed at membrane proteins.
Aguayo-Ortiz R, Creech J, Jimenez-Vazquez E, Guerrero-Serna G, Wang N, Monteiro da Rocha A
Sci Rep. 2021; 11(1):16580.
PMID: 34400719
PMC: 8368179.
DOI: 10.1038/s41598-021-96217-7.
Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter.
Palko-Labuz A, Blaszczyk M, Sroda-Pomianek K, Wesolowska O
Molecules. 2021; 26(15).
PMID: 34361789
PMC: 8347294.
DOI: 10.3390/molecules26154637.
Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics.
Alhadrami H, Sayed A, Hassan H, Youssif K, Gaber Y, Moatasim Y
Antibiotics (Basel). 2021; 10(5).
PMID: 34066998
PMC: 8150330.
DOI: 10.3390/antibiotics10050542.
The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors.
Cuthbertson C, Guo H, Kyani A, Madak J, Arabzada Z, Neamati N
ACS Pharmacol Transl Sci. 2020; 3(6):1242-1252.
PMID: 33344900
PMC: 7737209.
DOI: 10.1021/acsptsci.0c00124.